Dublin, June 25, 2019 (GLOBE NEWSWIRE) -- The "Global Benign Prostatic Hyperplasia Market: Growth, Trends, and Forecasts (2019-2024)" report has been added to ResearchAndMarkets.com's offering. Benign ...

Objective: The objective of this study was todirectly assess the likelihood and timing of alphablocker discontinuation in patients receivingcombination therapy with dutasteride orfinasteride plus an ...

Old man taking a pill New study is the largest to date assessing cardiovascular risks in patients taking alpha blockers. Men who take alpha blockers (ABs) rather than 5-alpha reductase inhibitors ...

Modern medical research shows that drug and surgical treatments for benign prostatic hyperplasia and chronic prostatitis carry high risks, while Dr Allen's Device, developed by Fine Treatment, an ...

A meta-analysis evaluated the efficacy and safety of imidafenacin for overactive bladder induced by benign prostatic hyperplasia. Combining imidafenacin with an alpha-blocker may effectively treat ...

DEAR DR. ROACH: I have benign prostatic hyperplasia (BPH), and I am taking tamsulosin daily. It works and helps with my daily urination. How long should I continue to take it? Are there any related ...

This article presents background information and highlights key findings from a managed care perspective related to enlarged prostate (EP) in Medicare-eligible patients. This article does not provide ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...

Dear Dr. Roach: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn’t provide any ...

In a small study, add-on vibegron appeared well-tolerated and clinically effective among men with persistent OAB. Vibegron add-on therapy is both safe and effective for men with persistent storage ...

The American Urological Association (AUA) has updated its guidelines on managing male lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). The updates, the first since ...